Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-023538

Chief Operating Officer gave up 6,903 shares (to pay taxes)

  • Chief Operating Officer acquired 12,307 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BILINSKY IGOR · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Exercise or conversion : show line 1 in the form +12,307 118,051 D
2026-03-02 Shares withheld for taxes : show line 2 in the form −6,903 $3.79 $26,162 111,148 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-02 Exercise or conversion : show line 3 in the form Restricted Stock Units −8,790 35,159 D
2026-03-02 Exercise or conversion : show line 4 in the form Restricted Stock Units −3,517 0 D
Loading xslF345X05/tm267902-3_4seq1.xml…